Literature DB >> 11316901

Detection of fetal HPCs in maternal circulation after delivery.

H Osada1, S Doi, T Fukushima, H Nakauchi, K Seki, S Sekiya.   

Abstract

BACKGROUND: Circulation of mature fetal blood cells in the maternal blood for a certain postpartum period has been verified, but detailed study of the fetal HPCs has not been reported. The objective of this study was to evaluate the frequency and clearance of these cells in the peripheral blood of puerperal women. STUDY DESIGN AND METHODS: PBMNCs from 15 puerperal women who gave birth to male infants were cultured in semi-solid medium containing hematopoietic stimulating factors. Colonies formed in the medium were individually characterized, collected, and subjected to PCR amplification of the SRY gene on Y chromosome to confirm fetal origin.
RESULTS: The mean numbers of fetal progenitor cell colonies isolated per mL of maternal blood were 1.63, 2.48, 0.56, 0.12, and 0 on the day of delivery, at 4 days, 1 month, 6 months, and 1 year after delivery, respectively. There was no difference in the ratio of fetal versus maternal colonies between erythroid and granulocyte/macrophage lineages.
CONCLUSION: The present study demonstrated that a significant number of fetal HPCs circulate in the maternal blood for a duration of at least 6 months after delivery.

Entities:  

Mesh:

Year:  2001        PMID: 11316901     DOI: 10.1046/j.1537-2995.2001.41040499.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  10 in total

1.  Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.

Authors:  Olivia J Holland; Caitlin Linscheid; Herbert C Hodes; Traci L Nauser; Melissa Gilliam; Peter Stone; Larry W Chamley; Margaret G Petroff
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

Review 2.  A natural stem cell therapy? How novel findings and biotechnology clarify the ethics of stem cell research.

Authors:  P Patel
Journal:  J Med Ethics       Date:  2006-04       Impact factor: 2.903

3.  Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation.

Authors:  Rina J Kara; Paola Bolli; Ioannis Karakikes; Iwao Matsunaga; Joseph Tripodi; Omar Tanweer; Perry Altman; Neil S Shachter; Austin Nakano; Vesna Najfeld; Hina W Chaudhry
Journal:  Circ Res       Date:  2011-11-14       Impact factor: 17.367

Review 4.  Review: Fetal antigens--identity, origins, and influences on the maternal immune system.

Authors:  M G Petroff
Journal:  Placenta       Date:  2011-01-05       Impact factor: 3.481

5.  Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells.

Authors:  Sau Nguyen Huu; Michèle Oster; Serge Uzan; Fabrice Chareyre; Sélim Aractingi; Kiarash Khosrotehrani
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

Review 6.  Feto-maternal cell trafficking: a transfer of pregnancy associated progenitor cells.

Authors:  Sau Nguyen Huu; Gil Dubernard; Selim Aractingi; Kiarash Khosrotehrani
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 7.  Cell migration from baby to mother.

Authors:  Gavin S Dawe; Xiao Wei Tan; Zhi-Cheng Xiao
Journal:  Cell Adh Migr       Date:  2007-01-28       Impact factor: 3.405

Review 8.  Stem cells and female reproduction.

Authors:  Hongling Du; Hugh S Taylor
Journal:  Reprod Sci       Date:  2009-02       Impact factor: 3.060

9.  Ccl2/Ccr2 signalling recruits a distinct fetal microchimeric population that rescues delayed maternal wound healing.

Authors:  Mathieu Castela; Dany Nassar; Maria Sbeih; Marie Jachiet; Zhe Wang; Selim Aractingi
Journal:  Nat Commun       Date:  2017-05-18       Impact factor: 14.919

10.  Unravelling the biological secrets of microchimerism by single-cell analysis.

Authors:  Anders Ståhlberg; Amin El-Heliebi; Peter Sedlmayr; Thomas Kroneis
Journal:  Brief Funct Genomics       Date:  2018-07-01       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.